Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion

NCT05001061 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2021-08-11

No results posted yet for this study

Summary

Efficacy of sublingual versus vaginal misoprostol in termination of first trimester missed abortion

Conditions

  • Missed Abortion

Interventions

DRUG

Misoprostol Pill

sublingual versus vaginal Misoprostol in termination of first trimester missed abortion

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-03
Primary Completion
2021-10-15
Completion
2021-10-16

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05001061 on ClinicalTrials.gov